Today news
About the same in other media
Sebi green lights issues of Sagility, Senores Pharma
Reading now: 386
Sagility India and Senores Pharmaceuticals have received approvals from the Securities and Exchange Board of India (Sebi) for their proposed initial public offerings (IPOs). The regulator issued its final observations on the draft papers last week.
When a company receives a final observation from Sebi, it’s a signal from the regulator to go ahead with the IPO process. Sagility India’s IPO consists solely of an offer for sale (OFS) of 984.4 million shares by promoter Sagility BV. The company provides technology-driven services to insurance settlement entities and healthcare providers.
Senores’ IPO comprises a fresh issue of Rs 500 crore and an OFS of 2.7 million shares by promoters and other investors.
(You can now subscribe to our ETMarkets WhatsApp channel)
Read more on economictimes.indiatimes.com
About this in other media
Mint Explainer: Why have stockbrokers invited Sebi's scrutiny? livemint.com /1 week ago
India's Adani Green units plan to raise up to $1 billion in dollar bonds, bankers say economictimes.indiatimes.com /1 week ago
Centre's plan to raise ₹20,000 cr via green bonds is conditional on greenium livemint.com /1 week ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
